Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Genomics Receives Nasdaq Non-Compliance Letter

NEW YORK (GenomeWeb) – Rosetta Genomics said today that it has received notification that it is no longer in compliance with the Nasdaq's $1 minimum bid price requirement for continued listing.

According to Rosetta, it received a letter from the Nasdaq stating that the closing bid price of its shares have been below the exchange's required $1 level for the past 30 consecutive business days. The diagnostics firm said that its shares must trade at or above $1 for a minimum of 10 consecutive business days within a 180-day period ending on May 29 in order to regain compliance.

Rosetta added that it may receive an additional 180-day grace period if it meets the Nasdaq's other initial listing standards.

Earlier this year, Rosetta effected a 1-for-12 reverse stock split after failing to meet the Nasdaq's minimum bid price requirement. Last month, the company was notified that it no longer met the Nasdaq's stockholder equity listing requirement.

During morning trading, shares of Rosetta were down a fraction of a percent at $.72.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.